Skip to main content
. 2021 May 2;13(1):e12180. doi: 10.1002/dad2.12180

TABLE 4.

Characteristics by cognitive trajectory class of Symbol Digit Modalities Test (SDMT; n = 17,883)

Class, N (%)
Baseline characteristics Very high/stable 456 (2.6) High/minor decline 3025 (16.9) Medium/minor decline 4869 (27.2) Medium‐low/minor decline 5002 (28.0) Low/minor decline 3314 (18.5) Very low/minor decline 1217 (6.8) P‐value*
Age, years <.001
65–69 a 13 (2.9) 106 (3.5) 133 (2.7) 119 (2.4) 83 (2.5) 29 (2.4)
65–74 371 (81.4) 2166 (71.6) 3096 (63.6) 2718 (54.3) 1363 (41.1) 328 (27.0)
75–84 71 (15.6) 739 (24.4) 1567 (32.2) 1998 (39.9) 1650 (49.8) 689 (56.6)
≥85 1 (0.2) 14 (0.5) 73 (1.5) 167 (3.3) 218 (6.6) 171 (14.1)
Sex <.001
Male 130 (28.5) 1034 (34.2) 1971 (40.5) 2370 (47.4) 1673 (50.5) 652 (53.6)
Female 326 (71.5) 1991 (65.8) 2898 (59.5) 2632 (52.6) 1641 (49.5) 565 (46.4)
Ethnicity <.001
Australian White 372 (81.6) 2532 (83.7) 4198 (86.2) 4386 (87.7) 2887 (87.1) 1,022 (84.0)
US White 59 (12.9) 280 (9.3) 324 (6.7) 217 (4.3) 118 (3.6) 27 (2.2)
Black 12 (2.6) 120 (4.0) 166 (3.4) 204 (4.1) 167 (5.0) 97 (8.0)
Hispanic/Latino 5 (1.1) 50 (1.7) 104 (2.1) 125 (2.5) 98 (3.0) 52 (4.3)
Other 8 (1.8) 43 (1.4) 77 (1.6) 70 (1.4) 44 (1.3) 19 (1.6)
Education, years <.001
 < 12 110 (24.1) 896 (29.6) 1849 (38.0) 2418 (48.3) 1916 (57.8) 856 (70.3)
12–15 134 (29.4) 943 (31.2) 1478 (30.4) 1468 (29.4) 906 (27.3) 254 (20.9)
≥16 212 (46.5) 1186 (39.2) 1542 (31.7) 1116 (22.3) 492 (14.9) 107 (8.8)
Randomization group <0.001
Aspirin group 214 (46.9) 1513 (50.0) 2391 (49.1) 2506 (50.1) 1681 (50.7) 603 (49.6)
Placebo group 242 (53.1) 1512 (50.0) 2478 (50.9) 2496 (49.9) 1633 (49.3) 614 (50.4)
Incident dementia <.001
Yes 0 (0.0) 9 (0.3) 39 (0.8) 101 (2.0) 201 (6.1) 188 (15.5)
No 456 (100.0) 3016 (99.7) 4830 (99.2) 4901 (98.0) 3113 (93.9) 1029 (84.5)
Median (inter‐quartile range)
Length of follow‐up, years 4 (3‐5) 4 (3‐5) 3 (3‐5) 3 (3‐5) 3 (3‐5) 3 (1‐5) <.001
Number of cognitive assessments 4 (3‐4) 3 (3‐4) 3 (3‐4) 3 (3‐4) 3 (3‐4) 3 (2‐4) <.001
a

Only includes U.S. Black or Hispanic/Latino individuals, who were eligible to enroll from 65 years and over (all other individuals needed to be aged at least 70 years to be eligible).

*

P‐values were based on chi‐squared tests or Fisher's exact tests for categorical variables, and Kruskal‐Wallis H‐tests for length of follow‐up.

Note: The labels of the trajectory classes correspond to those shown in Figure 1D.